Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens

BACKGROUND: Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) can contribute to virologic failure and limit retreatment options. People who inject drugs (PWID) are at highest risk for transmission of resistant virus. We report on RASs at baseline and after virologic f...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Matthew J, Riback, Lindsey, Reeves, Jacqueline D, Lie, Yolanda S, Agyemang, Linda, Norton, Brianna L, Arnsten, Julia H, Litwin, Alain H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530260/
https://www.ncbi.nlm.nih.gov/pubmed/34692891
http://dx.doi.org/10.1093/ofid/ofab474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530260/
https://www.ncbi.nlm.nih.gov/pubmed/34692891
http://dx.doi.org/10.1093/ofid/ofab474

Ejemplares similares